| |
| |
|
| Insider
Information: |
Kwon Young |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
301,441 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,761,200 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
301,441 |
|
|
| Total
Value |
$2,761,200 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 74.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Chief Financial & Bus.... |
2020-10-01 |
0 |
2018-04-19 |
0 |
Premium* |
|
|
ADMA Biologics Inc |
ADMA |
|
2024-02-26 |
301,441 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMA |
ADMA Biologics Inc |
|
– • – |
2021-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-06-05 |
4 |
AS |
$24.90 |
$25 |
D/D |
(1) |
137,623 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial & Bus. Officer |
• – – |
2020-02-11 |
4 |
AS |
$32.23 |
$11,281 |
D/D |
(350) |
111,619 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-21 |
4 |
AS |
$23.40 |
$8,213 |
D/D |
(351) |
140,624 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-02-20 |
4 |
AS |
$14.05 |
$4,932 |
D/D |
(351) |
125,883 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-10 |
4 |
AS |
$21.95 |
$7,726 |
D/D |
(352) |
141,975 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-05-10 |
4 |
AS |
$14.00 |
$4,956 |
D/D |
(354) |
96,520 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial & Bus. Officer |
• – – |
2020-02-10 |
4 |
AS |
$31.50 |
$12,852 |
D/D |
(408) |
111,969 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-02-12 |
4 |
AS |
$12.77 |
$5,287 |
D/D |
(414) |
111,542 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-05-08 |
4 |
AS |
$13.68 |
$5,732 |
D/D |
(419) |
96,874 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-05-08 |
4 |
AS |
$18.08 |
$8,913 |
D/D |
(493) |
142,827 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-02-08 |
4 |
AS |
$11.52 |
$5,691 |
D/D |
(494) |
111,956 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-08-21 |
4 |
AS |
$27.25 |
$14,388 |
D/D |
(528) |
111,343 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-11-12 |
4 |
AS |
$16.18 |
$8,559 |
D/D |
(529) |
108,703 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2018-11-12 |
4 |
AS |
$13.15 |
$6,970 |
D/D |
(530) |
111,576 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-08-10 |
4 |
AS |
$25.70 |
$13,647 |
D/D |
(531) |
111,871 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-08-12 |
4 |
AS |
$11.64 |
$6,204 |
D/D |
(533) |
100,819 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2018-11-20 |
4 |
AS |
$12.30 |
$6,581 |
D/D |
(535) |
111,041 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-08-08 |
4 |
AS |
$11.82 |
$7,399 |
D/D |
(626) |
101,362 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial & Bus. Officer |
• – – |
2020-05-08 |
4 |
AS |
$33.30 |
$20,946 |
D/D |
(629) |
141,502 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-08-08 |
4 |
AS |
$29.00 |
$18,328 |
D/D |
(632) |
112,402 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-11-08 |
4 |
AS |
$16.06 |
$10,150 |
D/D |
(632) |
109,232 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Business Officer |
• – – |
2019-08-08 |
4/A |
AS |
$11.67 |
$7,422 |
D/D |
(636) |
101,352 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Corporate Development |
• – – |
2018-11-08 |
4 |
AS |
$14.09 |
$9,102 |
D/D |
(646) |
112,106 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Chief Financial & Bus. Officer |
• – – |
2020-08-10 |
4 |
AS |
$32.36 |
$21,099 |
D/D |
(652) |
160,633 |
0 |
% |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
